Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for DILANTIN-125
- A Study to Assess the Effect of Itraconazole, Phenytoin, and Gemfibrozil on the Drug Levels of BMS-986166 in Healthy Participants
- Comparative Trial of IV Lacosamide Versus Phenytoin for Seizure Management
- A Study to Assess if Epanutin Infatabs 50 mg From Germany Are Similar to Dilantin Infatabs 50 mg From Australia
- A Pilot Study of NSICU Assessment of Seizure Prophylaxis With Lacosamide
- Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
- Busulfan Plus Cyclophosphamide vs Fludarabine as a Conditioning Regimen
- Steady-State Study of Extended Phenytoin Sodium Capsules 100 mg and Dilantin® Kapseals® 100 mg
- Assess Safety and Efficacy of Levetiracetam(LEV;Keppra)for Seizure Prevention
- PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas
- Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas
- Evaluating the Transporter Protein Inhibitor Probenecid In Patients With Epilepsy
- Preventing Epilepsy After Traumatic Brain Injury With Topiramate
- Phenytoin as a Neuroprotective Agent Against Corticosteroid-induced Functional Imaging Changes
- Phenytoin and Driving Safety: A Randomized, Controlled Cross-Over Study
- Bone Marrow Transplantation, Hemoglobinopathies, SCALLOP
- Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer
- IV Keppra in the Emergency Department for Prevention of Early Recurrent Seizures
- Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors
- Testosterone and Physical Function in HIV+ Men
- Dilantin Levels With Continuous Delivery of Enteral Feedings - A Pilot Study
- Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors
- Bone Marrow Transplant From Related Donor for Patients With High Risk Hemoglobinopathies
- Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma
Clinical trials list
click for details